Skip to main content

Animations

Etty (Tika) N. Benveniste, PhD

Senior Vice Dean for Basic Sciences and Charlene A. Jones Endowed Chair in Neuroimmunology at University of Alabama at Birmingham
Location: Birmingham, AL United States

Tika Benveniste, PhD, is Senior Vice Dean, UAB Heersink SOM. She was the Founding Chair of the Department of Cell, Developmental and Integrative Biology (2012-2015), and served as Chair of the Department of Cell Biology (2000-2011). Dr. Benveniste was elected in 2009 as a Fellow of the AAAS. She serves as Chair, Scientific Advisory Committee, National Multiple Sclerosis Society.

As Senior Vice Dean, Dr. Benveniste oversees faculty recruitment/retention, internal funding mechanisms, space allocations/metrics/renovations, Core Facilities, compliance issues, and strategic research planning. 

Dr. Benveniste’s lab focuses on neuroimmunology, studying the interaction of innate and adaptive immune cells with glia, specifically signaling mediated by the JAK/STAT pathway in terms of neuroinflammatory responses. These studies have implications for autoimmune/neurodegenerative diseases such as Multiple Sclerosis, Parkinson’s Disease and Alzheimer’s Disease. Her laboratory has over 260 publications in highly-ranked journals. Dr. Benveniste’s research is supported by grants from the NIH and The Michael J. Fox Foundation.

Dr. Benveniste has mentored over 280 high school students, undergraduates, graduate students, medical students, postdoctoral fellows, and junior faculty. Thirty-six students have obtained their Ph.D. degree from her lab, and 34 postdoctoral fellows have been mentored by her.


Associated Grants

  • SUPPLEMENT: Cytokine Production by Adaptive Immune Cells from Patients with Parkinson’s Disease: Response to Diverse Biological Stimuli

    2025


  • Cytokine Production by Adaptive Immune Cells in Parkinson’s Disease: Response to Diverse Biological Stimuli

    2020


  • Role of the JAK/STAT Pathway in Parkinson's Disease

    2016


  • Targeting the JAK/STAT Pathway in the Treatment of Parkinson's Disease

    2012


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.